von Hoff DD - Search Results

1

A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.

Weiss GR, Kuhn JG, Rizzo J, Smith LS, Rodriguez GI, Eckardt JR, Burris HA 3rd, Fields S, VanDenBerg K, von Hoff DD. Weiss GR, et al. Among authors: von hoff dd. Cancer Chemother Pharmacol. 1995;35(5):397-402. doi: 10.1007/s002800050253. Cancer Chemother Pharmacol. 1995. PMID: 7850921 Clinical Trial.

2

A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days.

Wall JG, Burris HA 3rd, Von Hoff DD, Rodriguez G, Kneuper-Hall R, Shaffer D, O'Rourke T, Brown T, Weiss G, Clark G, et al. Wall JG, et al. Among authors: von hoff dd. Anticancer Drugs. 1992 Aug;3(4):337-45. doi: 10.1097/00001813-199208000-00004. Anticancer Drugs. 1992. PMID: 1330081 Clinical Trial.

3

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.

Burris HA 3rd, Hanauske AR, Johnson RK, Marshall MH, Kuhn JG, Hilsenbeck SG, Von Hoff DD. Burris HA 3rd, et al. Among authors: von hoff dd. J Natl Cancer Inst. 1992 Dec 2;84(23):1816-20. doi: 10.1093/jnci/84.23.1816. J Natl Cancer Inst. 1992. PMID: 1331485

4

Clinical trials with the topoisomerase I inhibitors.

Burris HA, Rothenberg ML, Kuhn JG, Von Hoff DD. Burris HA, et al. Among authors: von hoff dd. Semin Oncol. 1992 Dec;19(6):663-9. Semin Oncol. 1992. PMID: 1334279 Review.

5

Preclinical leads for innovative uses for etoposide.

Von Hoff DD, McGill J, Davidson K, Forseth B, Atef Ebrahim el-Zayat A, Burris H. Von Hoff DD, et al. Semin Oncol. 1992 Dec;19(6 Suppl 13):10-3. Semin Oncol. 1992. PMID: 1492222

6

A phase I trial of taxol given by a 6-hour intravenous infusion.

Brown T, Havlin K, Weiss G, Cagnola J, Koeller J, Kuhn J, Rizzo J, Craig J, Phillips J, Von Hoff D. Brown T, et al. J Clin Oncol. 1991 Jul;9(7):1261-7. doi: 10.1200/JCO.1991.9.7.1261. J Clin Oncol. 1991. PMID: 1675263 Clinical Trial.

7

Phase I clinical trials with fludarabine phosphate.

Von Hoff DD. Von Hoff DD. Semin Oncol. 1990 Oct;17(5 Suppl 8):33-8. Semin Oncol. 1990. PMID: 1699281 Review.

8

Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.

Von Hoff DD, Green S, Surwit EA, Hannigan EV, Alberts DS. Von Hoff DD, et al. Am J Clin Oncol. 1990 Oct;13(5):433-5. doi: 10.1097/00000421-199010000-00014. Am J Clin Oncol. 1990. PMID: 1699401 Clinical Trial.

9

Phase I clinical and pharmacokinetic trial of flavone acetic acid.

Havlin KA, Kuhn JG, Craig JB, Boldt DH, Weiss GR, Koeller J, Harman G, Schwartz R, Clark GN, Von Hoff DD. Havlin KA, et al. Among authors: von hoff dd. J Natl Cancer Inst. 1991 Jan 16;83(2):124-8. doi: 10.1093/jnci/83.2.124. J Natl Cancer Inst. 1991. PMID: 1703237 Clinical Trial.

10

Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.

Von Hoff DD, Green S, Alberts DS, Stock-Novack DL, Surwit EA, Miller TP, Stephens RL. Von Hoff DD, et al. Am J Clin Oncol. 1991 Jun;14(3):193-4. doi: 10.1097/00000421-199106000-00004. Am J Clin Oncol. 1991. PMID: 1709556 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters